Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 6, 2021; 9(28): 8327-8339
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8327
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8327
Figure 2 Effect of conventional and alternative drugs in diabetic patients with coronavirus disease 2019.
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; ACE: Angiotensin converting enzyme; ARB: Angiotensin II receptor blocker; TZD: Thiazolidinediones; GLP-1: Glucagon-like peptide 1; DPP4: Dipeptidyl peptidase 4; hrsACE2: Human recombinant soluble angiotensin converting enzyme 2.
- Citation: Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases 2021; 9(28): 8327-8339
- URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8327.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8327